GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » Receivables Turnover

Novo Nordisk A/S (Novo Nordisk A/S) Receivables Turnover : 1.13 (As of Dec. 2023)


View and export this data going back to 1981. Start your Free Trial

What is Novo Nordisk A/S Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Novo Nordisk A/S's Revenue for the three months ended in Dec. 2023 was $9,636 Mil. Novo Nordisk A/S's average Accounts Receivable for the three months ended in Dec. 2023 was $8,502 Mil. Hence, Novo Nordisk A/S's Receivables Turnover for the three months ended in Dec. 2023 was 1.13.


Novo Nordisk A/S Receivables Turnover Historical Data

The historical data trend for Novo Nordisk A/S's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Receivables Turnover Chart

Novo Nordisk A/S Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.06 5.04 3.99 3.77 4.08

Novo Nordisk A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.03 1.06 0.98 1.02 1.13

Competitive Comparison of Novo Nordisk A/S's Receivables Turnover

For the Biotechnology subindustry, Novo Nordisk A/S's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novo Nordisk A/S's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novo Nordisk A/S's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Novo Nordisk A/S's Receivables Turnover falls into.



Novo Nordisk A/S Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Novo Nordisk A/S's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=33982.121 / ((7199.305 + 9476.503) / 2 )
=33982.121 / 8337.904
=4.08

Novo Nordisk A/S's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

Receivables Turnover (Q: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Dec. 2023 ) / ((Accounts Receivable (Q: Sep. 2023 ) + Accounts Receivable (Q: Dec. 2023 )) / count )
=9636.42 / ((7527.799 + 9476.503) / 2 )
=9636.42 / 8502.151
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novo Nordisk A/S  (NYSE:NVO) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Novo Nordisk A/S Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.